Literature DB >> 1194278

Eukaryotic initiation complex formation. Evidence for two distinct pathways.

S L Adams, B Safer, W F Anderson, W C Merrick.   

Abstract

Two distinct pathways have been elucidated which lead to the formation of an AUG-dependent initiation complex. One pathway involves the use of initiation factor M1 (IF-M1) to promote AUG-dependent binding of the initiator tRNA to the 40 S subunit, followed by joining of the 60 S subunit in the presence of IF-M2A, IF-M2B, and GTP. The second pathway involves the IF-MP-directed binding of initiator tRNA to the 40 S subunit via a ternary complex of IF-MP-GTP-Met-tRNAf. This reaction does not require AUG codon. However, subsequent formation of an 80 S initiation complex (as determined by methionyl-puromycin synthesis) required AUG as well as IF-M2A, IF-M2B, and GTP. Since both pathways require the same complementary initiation factors (at the same level), it would appear that the only difference is the manner in which the initiator tRNA is bound to the 40 S subunit, either by IF-M1 or IF-MP. Examination of the requirements for endogenous mRNA-directed methionyl-puromycin synthesis indicates a greater difference between IF-MP and IF-M1 in that only IF-MP was capable of forming an 80 S initiation complex which was sensitive to puromycin.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1194278

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  GTP-independent tRNA delivery to the ribosomal P-site by a novel eukaryotic translation factor.

Authors:  Sergey E Dmitriev; Ilya M Terenin; Dmitri E Andreev; Pavel A Ivanov; Jacov E Dunaevsky; William C Merrick; Ivan N Shatsky
Journal:  J Biol Chem       Date:  2010-06-21       Impact factor: 5.157

2.  Purification and characterization of initiation factor IF-E3 from rabbit reticulocytes.

Authors:  R Benne; J W Hershey
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

3.  Polypeptide chain initiation in eukaryotes: mechanism of formation of initiation complex.

Authors:  C Nombela; N A Nombela; S Ochoa; B Safer; W F Anderson; W C Merrick
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

4.  Translational resistance of late alphavirus mRNA to eIF2alpha phosphorylation: a strategy to overcome the antiviral effect of protein kinase PKR.

Authors:  Iván Ventoso; Miguel Angel Sanz; Susana Molina; Juan José Berlanga; Luis Carrasco; Mariano Esteban
Journal:  Genes Dev       Date:  2006-01-01       Impact factor: 11.361

5.  Characterization of the functional role of nucleotides within the URE2 IRES element and the requirements for eIF2A-mediated repression.

Authors:  Lucas C Reineke; William C Merrick
Journal:  RNA       Date:  2009-10-27       Impact factor: 4.942

Review 6.  Cellular IRES-mediated translation: the war of ITAFs in pathophysiological states.

Authors:  Anton A Komar; Maria Hatzoglou
Journal:  Cell Cycle       Date:  2011-01-15       Impact factor: 4.534

7.  Identification of a substrate site for transglutaminases on the human protein synthesis initiation factor 5A.

Authors:  S Beninati; L Nicolini; J Jakus; A Passeggio; A Abbruzzese
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

8.  The control of protein synthesis by hemin in rabbit reticulocytes.

Authors:  M Gross
Journal:  Mol Cell Biochem       Date:  1980-05-28       Impact factor: 3.396

9.  Effects of translation initiation factor eIF-5A on the functioning of human T-cell leukemia virus type I Rex and human immunodeficiency virus Rev inhibited trans dominantly by a Rex mutant deficient in RNA binding.

Authors:  J Katahira; T Ishizaki; H Sakai; A Adachi; K Yamamoto; H Shida
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

10.  Binding of ribosomes to 5'-terminal leader sequences of eukaryotic messenger RNAs.

Authors:  W Filipowicz; A L Haenni
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.